Tachycardia Treatment
Rapid heart rates can originate from either the atria or the ventricles of the heart. The treatment for your tachycardia may vary between medication or surgery depending on the severity of your condition. Rhythms from the ventricle are more often considered life-threatening.
Treatment goals
At the UPMC Heart and Vascular Institute's Cardiac Electrophysiology Program, the goals of tachycardia treatment are to:
- Minimize stroke risk
- Control heart rate
- Restore normal heart rhythm
Your doctor may prescribe medications and order certain procedures to meet these treatment goals.
Medicines for treating tachycardia
Medicines used to slow the heart rate:
- Digitalis or Digoxin
- Verapamil
- Diltiazem (Cardizem®)
- Metoprolol (Lopressor® or Toprol-XL®)
- Atenolol
Medicines used to maintain a regular heart rhythm:
- Sotalol (Betapace AF®)
- Propafenone (Rhythmol®)
- Amiodarone (Pacerone® or Cordarone®)
Medicines used to prevent clot formation and help reduce the risk of stroke:
- Blood thinners such as:
- Warfarin (Coumadin®)
- Aspirin
Stereotactic Body Radiation Therapy (SBRT) for Ventricular Tachycardia (V-tach)
SBRT is an experimental procedure for refractory ventricular tachycardia (V-tach), an arrhythmia that comes from the heart's lower chambers.
Doctors use SBRT if common treatments -- like drugs and catheter ablation — fail to control your v-tach.
SBRT involves the delivery of focused, intense doses of radiation to a small area of the heart.
Doctors use imaging scans to:
- Find the area of the heart causing the arrhythmia.
- Target the treatment.
- Help reduce the potential risks of damage, such as scarring, to tissue around the heart.
SBRT can treat a larger area of the heart than catheter ablation.
The procedure is noninvasive. In most cases, it lasts under an hour and you can go home the same day.
You will have frequent, extensive follow-up visits to check on SBRT's long-term effects.
Is SBRT an option for me?
Currently, SBRT is only for people with refractory V-tach who have tried other treatments without success.
Early data suggest SBRT can be more successful than other treatments in reducing arrhythmia in people with v-tach. But because SBRT is an experimental treatment, more long-term data is needed to determine its effectiveness.